Thank you for taking the time to complete this survey.
As you may be aware, the National Blood Authority, on behalf of the Australian Government, is currently reviewing the authorisation and clinical governance framework for intravenous immunoglobulin (IVIg). The key aim of this review is to develop recommendations to ensure the long-term sustainability of immunogobulin supply and equity of access between different patient groups.
The purpose of this survey is to understand your perspective and experience with regards to prescribing and on-going use of IVIg and normal immunoglobulin (NIg) for your patients.
The survey should take approximately 10 minutes to complete and responses can be provided anonymously.
We thank you for your time and cooperation with this survey. If you have any further questions, please contact: